Track market-moving stories before they get noisy

Posted by Defense World Staff on Apr 7th, 2026

Shares of Jackson Financial Inc. (NYSE:JXN – Get Free Report) have been given an average recommendation of “Hold” by the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $115.60.

A number of brokerages have recently commented on JXN. Weiss Ratings reissued a “hold (c+)” rating on shares of Jackson Financial in a research report on Monday, December 29th. Morgan Stanley set a $105.00 price objective on Jackson Financial in a research report on Monday, December 15th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $123.00 price objective on shares of Jackson Financial in a research report on Thursday, March 26th. Wall Street Zen raised Jackson Financial from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Evercore set a $118.00 price objective on Jackson Financial and gave the stock an “in-line” rating in a research report on Tuesday, January 6th.

Check Out Our Latest Report on Jackson Financial

Hedge Funds Weigh In On Jackson Financial Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Allworth Financial LP lifted its stake in Jackson Financial by 404.0% in the third quarter. Allworth Financial LP now owns 252 shares of the company’s stock valued at $26,000 after buying an additional 202 shares during the last quarter. Cullen Frost Bankers Inc. purchased a new stake in Jackson Financial in the third quarter valued at approximately $28,000. Twin Peaks Wealth Advisors LLC purchased a new stake in Jackson Financial in the second quarter valued at approximately $30,000. Optiver Holding B.V. lifted its stake in Jackson Financial by 469.2% in the third quarter. Optiver Holding B.V. now owns 296 shares of the company’s stock valued at $30,000 after buying an additional 244 shares during the last quarter. Finally, Bayforest Capital Ltd lifted its stake in Jackson Financial by 541.2% in the third quarter. Bayforest Capital Ltd now owns 327 shares of the company’s stock valued at $33,000 after buying an additional 276 shares during the last quarter. 89.96% of the stock is owned by institutional investors and hedge funds.

Jackson Financial Stock Up 2.1% NYSE JXN opened at $105.89 on Friday. Jackson Financial has a 52 week low of $64.70 and a 52 week high of $123.61. The company has a quick ratio of 0.27, a current ratio of 0.27 and a debt-to-equity ratio of 0.47. The business’s fifty day simple moving average is $110.72 and its 200-day simple moving average is $105.36. The firm has a market cap of $7.48 billion, a PE ratio of -302.53 and a beta of 1.45.

Jackson Financial (NYSE:JXN – Get Free Report) last issued its quarterly earnings data on Wednesday, February 18th. The company reported $6.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.90 by $0.71. The business had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.92 billion. The firm’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the previous year, the business posted $4.65 earnings per share. As a group, equities analysts anticipate that Jackson Financial will post 20.55 earnings per share for the current year.

Jackson Financial Increases Dividend The firm also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Monday, March 16th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 3.4%. This is a positive change from Jackson Financial’s previous quarterly dividend of $0.80. The ex-dividend date of this dividend was Monday, March 16th. Jackson Financial’s dividend payout ratio is currently -1,028.57%.

Jackson Financial Company Profile (Get Free Report)

Jackson Financial Inc is a U.S.-based financial services holding company headquartered in Lansing, Michigan. The company operates primarily through its principal subsidiary, Jackson National Life Insurance Company, and specializes in designing and distributing retirement products. Jackson Financial has been publicly traded on the New York Stock Exchange under the ticker JXN since its initial public offering in May 2022.

The company’s core offerings include a broad range of fixed, variable and indexed annuity products aimed at helping individuals preserve and grow retirement assets.

See Also Five stocks we like better than Jackson Financial

Receive News & Ratings for Jackson Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jackson Financial and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBoot Barn (NYSE:BOOT) Trading 6.4% Higher After Analyst Upgrade

NEXT HEADLINE »Kratos Defense & Security Solutions (NASDAQ:KTOS) Shares Gap Up After Analyst Upgrade

Posted by Defense World Staff on Apr 10th, 2026

Accordant Advisory Group Inc acquired a new position in shares of Jackson Financial Inc. (NYSE:JXN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 15,731 shares of the company’s stock, valued at approximately $1,678,000. Jackson Financial comprises about 1.2% of Accordant Advisory Group Inc’s investment portfolio, making the stock its 20th largest holding.

Several other large investors have also made changes to their positions in the business. Wetzel Investment Advisors Inc. lifted its position in shares of Jackson Financial by 4.5% during the 4th quarter. Wetzel Investment Advisors Inc. now owns 2,300 shares of the company’s stock worth $245,000 after purchasing an additional 100 shares during the last quarter. Sound Income Strategies LLC lifted its position in shares of Jackson Financial by 25.5% during the 4th quarter. Sound Income Strategies LLC now owns 483 shares of the company’s stock worth $55,000 after purchasing an additional 98 shares during the last quarter. Rathbones Group PLC lifted its position in shares of Jackson Financial by 1.5% during the 4th quarter. Rathbones Group PLC now owns 27,453 shares of the company’s stock worth $2,928,000 after purchasing an additional 396 shares during the last quarter. Saxony Capital Management LLC acquired a new position in shares of Jackson Financial during the 4th quarter worth about $206,000. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Jackson Financial by 1.3% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 124,084 shares of the company’s stock worth $13,334,000 after purchasing an additional 1,600 shares during the last quarter. Institutional investors and hedge funds own 89.96% of the company’s stock.

Analyst Ratings Changes Several equities analysts have commented on the company. Barclays cut their price target on Jackson Financial from $138.00 to $136.00 and set an “overweight” rating for the company in a report on Wednesday. Morgan Stanley set a $105.00 price target on shares of Jackson Financial in a report on Monday, December 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Jackson Financial in a report on Monday, December 29th. Wall Street Zen raised shares of Jackson Financial from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Finally, Evercore set a $118.00 price target on shares of Jackson Financial and gave the company an “in-line” rating in a report on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Jackson Financial has an average rating of “Hold” and a consensus price target of $115.40.

Check Out Our Latest Stock Analysis on JXN

Jackson Financial Trading Down 4.1% Shares of JXN opened at $103.31 on Friday. The stock has a 50 day simple moving average of $110.02 and a 200-day simple moving average of $105.38. Jackson Financial Inc. has a 1 year low of $68.74 and a 1 year high of $123.61. The stock has a market cap of $7.30 billion, a PE ratio of -295.17 and a beta of 1.45. The company has a current ratio of 0.27, a quick ratio of 0.27 and a debt-to-equity ratio of 0.47.

Jackson Financial (NYSE:JXN – Get Free Report) last released its quarterly earnings results on Wednesday, February 18th. The company reported $6.61 earnings per share for the quarter, beating analysts’ consensus estimates of $5.90 by $0.71. The business had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.92 billion. During the same period in the prior year, the business earned $4.65 earnings per share. The company’s revenue for the quarter was down 2.8% on a year-over-year basis. On average, sell-side analysts predict that Jackson Financial Inc. will post 20.55 EPS for the current fiscal year.

Jackson Financial Increases Dividend The firm also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Monday, March 16th were issued a dividend of $0.90 per share. The ex-dividend date of this dividend was Monday, March 16th. This represents a $3.60 dividend on an annualized basis and a yield of 3.5%. This is a positive change from Jackson Financial’s previous quarterly dividend of $0.80. Jackson Financial’s payout ratio is -1,028.57%.

About Jackson Financial (Free Report)

Jackson Financial Inc is a U.S.-based financial services holding company headquartered in Lansing, Michigan. The company operates primarily through its principal subsidiary, Jackson National Life Insurance Company, and specializes in designing and distributing retirement products. Jackson Financial has been publicly traded on the New York Stock Exchange under the ticker JXN since its initial public offering in May 2022.

The company’s core offerings include a broad range of fixed, variable and indexed annuity products aimed at helping individuals preserve and grow retirement assets.

Featured Articles Five stocks we like better than Jackson Financial

Receive News & Ratings for Jackson Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jackson Financial and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAberdeen Group plc Lowers Stock Holdings in LivaNova PLC $LIVN

NEXT HEADLINE »Accordant Advisory Group Inc Acquires New Holdings in Perpetua Resources Corp. $PPTA

LANSING, Mich.--(BUSINESS WIRE)--Jackson Financial Inc.1 (NYSE: JXN) (Jackson®) today announced that it will release first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Jackson's press release and supplemental financial materials will be available at investors.jackson.com. Jackson will host a conference call and webcast to discuss the results at 9 a.m. ET on Wednesday, May 6, 2026. The live webcast is open to the public and can be accessed at investors.jackson.com.

LANSING, Mich.--(BUSINESS WIRE)--Jackson Financial Inc. (NYSE: JXN) (Jackson®) today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights Retail annuity sales1 of $5.3 billion in the first quarter of 2026, up 31% from the first quarter of 2025, reflecting continued strong demand across our product suite Variable annuity sales1 of $2.5 billion were down 6% from the first quarter of 2025, primarily reflecting lower sales of products with li.

2 hours ago

Church & Dwight (NYSE:CHD) Director Robert Shearer Sells 8,600 SharesMarketBeat

Church & Dwight Co., Inc. (NYSE:CHD - Get Free Report) Director Robert Shearer sold 8,600 shares of the business's stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $97.97, for a total transaction of $842,542.00. Following the completion of the sale, the director directly owned 30,678 shares in the company, valued at $3,005,523.66. This trade represents a 21.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

NYSE:CHD

LANSING, Mich.--(BUSINESS WIRE)--Jackson National Life Insurance Company® (Jackson®), the main operating subsidiary of Jackson Financial Inc.1 (NYSE: JXN), today launched Jackson Market Link Pro® 4 (JMLP4) and Jackson Market Link Pro Advisory® 4 (JMLPA4), further strengthening Jackson's suite of registered index-linked annuities (RILAs). JMLP4 (commission-based) and JMLPA4 (fee-based) provide clients the potential to grow assets before and during retirement while offering different degrees of p.

Wall Street expects a year-over-year increase in earnings on higher revenues when Sensata (ST - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 28. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis maker of sensing, electrical protection, control and power management products is expected to post quarterly earnings of $0.84 per share in its upcoming report, which represents a year-over-year change of +7.7%.

Revenues are expected to be $928 million, up 1.8% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Sensata?For Sensata, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.60%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Sensata will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Sensata would post earnings of $0.86 per share when it actually produced earnings of $0.88, delivering a surprise of +2.33%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Sensata appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies Reports First Quarter 2026 Financial Results.

Sensata (ST - Free Report) reported $934.8 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 2.6%. EPS of $0.86 for the same period compares to $0.78 a year ago.

The reported revenue represents a surprise of +0.73% over the Zacks Consensus Estimate of $928 million. With the consensus EPS estimate being $0.84, the EPS surprise was +2.99%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Sensata performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net revenue- Automotive: $524.8 million versus $528.9 million estimated by two analysts on average.Net revenue- Aerospace, Defense, and Commercial Equipment: $225.8 million versus the two-analyst average estimate of $203.79 million.Net revenue- Industrials: $184.2 million versus the two-analyst average estimate of $194.76 million.Operating income- Automotive: $123.2 million versus $120.99 million estimated by two analysts on average.Operating income- Aerospace, Defense, and Commercial Equipment: $63.5 million versus $54.61 million estimated by two analysts on average.Operating income- Industrials: $50 million compared to the $55.21 million average estimate based on two analysts.View all Key Company Metrics for Sensata here>>>

Shares of Sensata have returned +26.5% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Key Takeaways ST reported Q1 EPS of 86 cents and revenue of $934.8M, both beating the consensus estimate.Sensata's Aerospace, Defense and Commercial Equipment segment rose 14.8%, driving top-line growth.ST expects Q2 revenue of $950M-$980M and EPS of 89-95 cents, indicating continued growth. Sensata Technologies Holding plc (ST - Free Report) reported first-quarter 2026 adjusted earnings per share (EPS) of 86 cents, up from 78 cents a year ago. The bottom line beat the Zacks Consensus Estimate by 2.4%.

Revenues for the quarter reached $934.8 million, up 2.6% from a year ago. The figure came near to the upper end of management’s expectations ($917-$937 million) and beat the consensus estimate by 0.7%. Strength Aerospace, Defense and Commercial Equipment segments drove the top-line performance.

Following the announcement, shares of ST lost around 3% in the after-market trading session yesterday. In the past year, shares have gained 97% compared with the Instruments-Control industry’s growth of 12.7%.

Image Source: Zacks Investment Research

Management stated that the company’s first-quarter performance met or surpassed expectations across all key metrics, reinforcing the strong momentum it is building. Management also highlighted that disciplined execution across the organization, along with an effective productivity engine, is driving results. Additionally, the company’s strategic initiatives are gaining pace, while its growth opportunities remain solid and promising.

Segmental Results of SensataSensata has realigned its structure into three operating segments — Automotive, Industrials, and Aerospace, Defense and Commercial Equipment, which are now reflected as its new reporting segments.

Automotive revenues (56.1% of total revenues) decreased 0.8% (up 0.7% on an organic basis) year over year to $524.8 million. The Automotive segment outperformed overall market production by roughly 4%.

Segmental adjusted operating income was $123.2 million compared with $120.3 million in the prior-year quarter.

Industrials revenues (19.7% of total revenues) were $184.2 million, down 0.8% (up 0.7% on an organic basis) year over year. The Industrials segment delivered organic growth despite softness in its end markets.

Segmental adjusted operating income was $50 million compared with $48.5 million in the prior-year quarter.

Aerospace, Defense and Commercial Equipment revenues (24.2% of total revenues) were $225.8 million, up 14.8% (up 16.7% on an organic basis) year over year. The Aerospace, Defense and Commercial Equipment segment showed broad-based year-over-year strength, with both Aerospace & Defense and Commercial Equipment delivering double-digit growth.

Segmental adjusted operating income was $63.5 million compared with $50.1 million in the prior-year quarter.

Other Details of Sensata's Q1Adjusted operating income was $174 million, up 4.5% year over year from $166.5 million. Adjusted operating margin expanded 30 basis points to 18.6%.

Adjusted EBITDA totaled $206.5 million in the quarter, up from $200.2 million in the previous-year quarter.

Total operating expenses were $793.2 million, up 0.5% year over year.

ST’s Cash Flow & LiquidityIn the quarter under discussion, Sensata generated $122.5 million of net cash from operating activities compared with $119.2 million in the prior-year quarter.

Free cash flow was $104.6 million compared with $86.6 million a year ago.

As of March 31, 2026, the company had $635.1 million in cash and cash equivalents and $2,829.4 million of net long-term debt compared with $573 million and $2,828.6 million, respectively, as of Dec. 31, 2025.

In the first quarter of 2026, Sensata returned approximately $42.6 million to shareholders, including $17.5 million in quarterly dividends and $25.1 million through share repurchases.

Sensata’s Q2 OutlookFor the second quarter of 2026, Sensata expects revenue in the range of $950 million to $980 million, representing year-over-year growth of 1% to 4% compared with $943 million in the prior-year quarter. At the midpoint of this guidance, revenue includes approximately $8 million related to expected tariff recovery from customers.

Adjusted operating income is projected between $182 million and $190 million, reflecting an increase of 2% to 6% from $179 million a year ago. Adjusted operating margin is anticipated to improve to 19.2–19.4% from 19% in the second quarter of 2025, indicating an expansion of 20 to 40 basis points.

Adjusted net income is expected to be in the range of $131 million to $139 million, marking a 3% to 9% increase from $127 million in the prior-year period.

Adjusted earnings per share are forecast between 89 and 95 cents, suggesting growth of 2% to 9% compared with 87 cents reported a year earlier.

ST’s Zacks RankSensata currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Performances of Other FirmsBadger Meter, Inc. (BMI - Free Report) reported EPS of 93 cents for first-quarter 2026, which missed the Zacks Consensus Estimate by 22.5%. The bottom line compared unfavorably with the year-ago quarter’s EPS of $1.30.

Quarterly net sales were $202.3 million, down 9% from $222.2 million in the year-ago quarter due to delayed project deployments and weaker-than-expected short-cycle order activity. The Zacks Consensus Estimate was pegged at $230.1 million.

SAP SE (SAP - Free Report) reported first-quarter 2026 non-IFRS EPS of €1.72 ($2.01), which increased 20% from the year-ago quarter. The Zacks Consensus Estimate was pegged at $1.92.

Driven by momentum in the cloud business, SAP reported total revenues on a non-IFRS basis of €9.56 billion ($11.2 billion), which increased 6% year over year (up 12% at constant currency or cc). The Zacks Consensus Estimate was pegged at $11.3 billion.

BlackBerry Limited (BB - Free Report) reported fourth-quarter fiscal 2026 non-GAAP EPS of 6 cents. The figure beat the company’s estimate of 3-5 cents. In the year-ago quarter, it reported a non-GAAP EPS of 3 cents. The Zacks Consensus Estimate was pegged at 5 cents per share.

BlackBerry reported quarterly revenue of $156 million, surpassing the top end of its guidance ($138-$148 million), driven by stronger-than-expected sales across both its QNX and Secure Communications divisions. Revenue also increased 10% year over year.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Sensata (ST - Free Report) Headquartered in Attleboro, MA, Sensata Technologies is a global industrial technology company that develops, manufactures and sells sensors and sensor-rich solutions as well as electrical protection components and systems.

ST is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Computer and Technology stock. ST has a Momentum Style Score of A, and shares are up 14.6% over the past four weeks.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.07 to $3.72 per share. ST boasts an average earnings surprise of +3.3%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, ST should be on investors' short list.

SWINDON, United Kingdom--(BUSINESS WIRE)---- $ST #DayOfService--Sensata Technologies held its U.S. Day of Service on May 7, when nearly 400 employees volunteered with 23 nonprofit partners across the country.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Sensata (ST - Free Report) Headquartered in Attleboro, MA, Sensata Technologies is a global industrial technology company that develops, manufactures and sells sensors and sensor-rich solutions as well as electrical protection components and systems.

ST is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 12.74; value investors should take notice.

Four analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.08 to $3.73 per share. ST boasts an average earnings surprise of +3.3%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, ST should be on investors' short list.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.

The Style Scores are broken down into four categories:

Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

#1 (Strong Buy) stocks have produced an unmatched +23.7% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Sensata (ST - Free Report) Headquartered in Attleboro, MA, Sensata Technologies is a global industrial technology company that develops, manufactures and sells sensors and sensor-rich solutions as well as electrical protection components and systems.

ST is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. ST has a Growth Style Score of B, forecasting year-over-year earnings growth of 9.1% for the current fiscal year.

For fiscal 2026, four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.08 to $3.73 per share. ST boasts an average earnings surprise of +3.3%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, ST should be on investors' short list.

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies Holding plc and Certain Subsidiaries Announce Early Tender Results and Amendment of Cash Tender Offers.

On June 02, 2026, Sensata Technologies Holding PLC ST shares rose 7.8% to a current price of $53.13. The stock has seen a significant increase in price performance, with a 52-week range of $25.63 to $53.84.

GF Value™ verdict: Current price is $53.13 vs GF Value™ of $33.94, indicating the stock is 56.5% overvalued.GF Score™ of 73/100 suggests the company is above average compared to peers.Notable signal: Insider activity shows that insiders sold $0.4M in the last 3 months with no buying activity. Is ST Overvalued or Undervalued? According to the GF Value™, Sensata Technologies Holding PLC ST is currently significantly overvalued. With a current price of $53.13, which is substantially higher than the GF Value™ estimate of $33.94, there is a 56.5% margin of overvaluation. This suggests that the stock may be trading at a premium relative to its intrinsic value, indicating a potential risk for investors. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

The overvaluation raises questions about the sustainability of the current price, especially given the lack of recent insider buying and the relatively low predictability rating of 1 star. Investors may want to exercise caution when considering the stock at this inflated price level.

How Does ST's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 171.4x 25.2x Forward P/E 14.3x N/A The current P/E (TTM) of 171.4x is significantly above its 5-year median P/E of 25.2x, indicating that the stock is trading at a much higher valuation compared to its historical averages. The forward P/E of 14.3x suggests a more favorable valuation outlook, but it is still essential to note that the current P/E is 580% above its 5-year median. This P/E analysis aligns with the GF Value™ verdict, reinforcing the conclusion that ST is overvalued.

What Does ST's GF Score™ Tell Us? Metric Rating GF Score™ 73/100 Financial Strength 5/10 Profitability 7/10 Growth 5/10 Valuation 3/10 Momentum 9/10 The GF Score™ of 73/100 indicates that Sensata Technologies is performing above average compared to its peers. The strongest aspect of the score is the momentum rank of 9/10, suggesting strong recent price performance. However, the weakest area is the valuation rank of 3/10, which is consistent with the overvaluation indicated by the GF Value™. The financial strength and profitability ranks are moderate, reflecting a balanced but cautious outlook on the company's financial health.

What Are Insiders Doing with ST Stock? In the last three months, insider activity has shown that insiders sold $0.4M worth of shares, with no buying activity reported. This trend could suggest a lack of confidence among insiders in the stock's current valuation or future prospects. Typically, insider selling may indicate that those closest to the company do not see enough value at current price levels, which could further reinforce the notion that the stock is overvalued.

What This Means for Investors Based on the GF Value™ assessment, Sensata Technologies Holding PLC ST is currently overvalued. The significant disparity between the current price and the GF Value™ suggests that investors may need to be cautious when considering an entry point into this stock.

For the complete analysis, visit the Sensata Technologies Holding PLC ST stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is ST's GF Score™?

ST's GF Score™ is 73/100, indicating above-average performance compared to its peers based on key financial metrics.

Is ST overvalued or undervalued?

ST is overvalued, with a current price of $53.13 compared to a GF Value™ of $33.94, reflecting a 56.5% overvaluation.

What is ST's P/E ratio?

ST's P/E (TTM) is 171.4x, which is significantly above its 5-year median P/E of 25.2x, indicating a high current valuation relative to its historical performance.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

A handful of OpenAI executives are transitioning into new roles, according to a report from Bloomberg. An OpenAI spokesperson confirmed the personnel changes to TechCrunch.

New sustainability platform reflects company's commitment to responsible sourcing, more
efficient manufacturing, and offsetting a portion of plastic footprint*†1

, /PRNewswire/ -- CooperVision announced today the launch of its MADE BETTER™ Promise—a new global sustainability platform focused on smarter, more sustainable choices.*†1 Built on years of CooperVision innovation in sustainability, MADE BETTER™ Promise is woven throughout the life of participating products, beginning with the MyDay® daily disposable family of contact lenses.*†1

As part of the MADE BETTER™ Promise, CooperVision's MADE BETTER™ Innovation with MyDay® is introducing mindful packaging material choices and manufacturing improvements that lowers the carbon impact.*†1 The company also continues to offset a portion of MyDay® plastic footprint through its plastic neutrality program.†‡2

Key elements of CooperVision's MADE BETTER™ Innovation include:

Use of ISCC PLUS-certified materials in the packaging of participating products, making CooperVision the first and only contact lens manufacturer to do so.*†§♦1,3 The plastic within MyDay® blisters is 100% ISCC PLUS-certified bio-attributed material sourced and allocated via the ISCC mass balance approach.¶3,4 Manufacturing processes intentionally designed to reduce carbon footprint through next-generation technologies and improved resource efficiency. *†**††‡‡1,5 Use of lower-carbon energy where possible across production operations.§§6 Manufacturing sites that recycle more than 90% of waste, helping conserve natural resources.♦♦7 MADE BETTER™ Innovation also encompasses CooperVision's plastic neutrality program with Plastic Bank, which supports the removal of plastic waste from coastal communities while creating positive socioeconomic impact.†‡2 To date, the program has enabled the collection and recycling of more than 659 million plastic bottles from coastal areas where plastic pollution is prevalent.¶¶8 

"CooperVision's sustainability progress begins with innovation—in materials, manufacturing, and the way we think about the full life cycle of our products.*†1 MADE BETTER™ Promise reflects how we are turning those innovations into real–world impact through thoughtful choices that benefit both People + Planet,*♦♦♦1,9 said Aldo Zucaro, Senior Director of Corporate Responsibility, CooperCompanies. "We're off to a strong start, delivering practitioners and their patients the same MyDay®—just made with less carbon." ****††††6

CooperVision's MADE BETTER™ Promise is an ongoing global commitment, with continued advancements in materials, technologies, and processes intended to further reduce environmental impact over time.*1

*CooperVision's MADE BETTER Innovation program has introduced lower-carbon inputs with traceable sourcing - including ISCC PLUS-certified, lower-carbon plastic and lower-carbon aluminum - into the primary packaging of the MyDay® range of products. It also refers to process improvements that have reduced waste, improved energy efficiency, and lowered greenhouse gas emissions during production of the MyDay® range of products. Methods and verification information are available at [coopervision.com/sustainability/methods].
†Through its partnership with Plastic Bank, CooperVision offsets a portion of its plastic footprint by funding the collection and recycling of plastic waste, equivalent in weight to the plastic used in participating soft contact lens products sold in participating countries, gathered within 30 miles of oceans or waterways in countries where Plastic Bank operates. Plastic weight is based on the total weight of plastic in the lens, blister, and secondary packaging, including laminates, adhesives, and auxiliary inputs (e.g. ink). This does not include plastic used during the manufacturing process.
‡Plastic used in participating CooperVision soft contact lens products is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink). The determination does not include plastic used during the manufacturing process for both these products and their packaging.
§'Packaging' refers to the blister pack that directly encloses each contact lens - the plastic tray sealed with an aluminum foil lid.
♦Determination is based on a review of the ISCC PLUS-certified public license database and publicly available information. ISCC PLUS-certified licenses are issued at supplier/site level and may not identify downstream brands. As of November 6, 2025, no other contact lens manufacturers were identified as using ISCC PLUS-certified plastic. ISCC License number ISCC-L-228, valid beginning April 6, 2026, along with CooperVision's internal documentation shows that 100% of the polypropylene used within the MyDay® blisters is ISCC PLUS-certified bio-attributed material sourced and allocated via the mass balance approach; certification does not imply physical segregation.
¶Foil lidding atop of the MyDay® blisters and the contact lenses themselves are not ISCC PLUS-certified.
**Refers to continuous manufacturing improvement processes undertaken by CooperVision to increase efficiency
††Carbon footprint is limited to Scope 1 and 2 emissions, defined as: Scope 1 emissions are direct emissions from owned or controlled sources. Scope 2 emissions are indirect emissions from the generation of purchased energy.
‡‡CooperVision's 2021 and 2022 Environmental, Social, and Governance Reports.
§§The MyDay® range of products are manufactured at two facilities that use lower-carbon energy sources. At CooperVision's Juana Díaz, Puerto Rico site, combined heat and power (CHP) technology generates electricity and thermal energy more efficiently than conventional grid-supplied electricity and separate heating systems. Based on CooperVision's scope 1 and scope 2 emissions data, total greenhouse gas emissions per manufactured lens at this facility in 2024 were approximately 30% lower than in 2021, prior to CHP startup. At its manufacturing facilities in the UK, CooperVision purchases 100% renewable energy.
♦♦SCS Global Services Certificate No. SCS-ZW-0018 verifies a recycling rate of 94.7% for the Juana Díaz, PR facility. SCS Global Services is an international leader in third-party certification, validation, and verification for environmental sustainability. CooperVision's internal records demonstrate an average recycling rate of over 90% for its MyDay® manufacturing facilities in the UK.
¶¶CooperVision, through its collaboration with Plastic Bank, has collected and recycled approximately 12.4M kg of plastic waste gathered within 30 miles of oceans or waterways in countries where Plastic Bank operates as of February 2026. Using Plastic Bank's metric of 1kg of plastic equaling 50 standard 202mm bottles, that will be the equivalent of approximately 659M plastic bottles.
♦♦♦As of October 3, 2025, more than 7,000 Plastic Bank collection members across 500+ communities in Indonesia, Egypt, and the Philippines have exchanged collected plastic waste for income and life-improving benefits (such as insurance, digital connectivity, grocery vouchers, and school supplies) through CooperVision's plastic neutrality program with Plastic Bank, cumulative since January 2021.
****Results compare 2024 with a 2021 baseline. Full life cycle assessment has been conducted in accordance with ISO 14067 and verified through independent critical review from a cradle-to-grave basis, which covers all product stages from raw material extraction to end-of-life. Details on methodology and verification are available at [coopervision.com/sustainability/methods].
††††Carbon reduction' and/or 'lower carbon' refer to a reduction in total greenhouse gas emissions, expressed as carbon dioxide equivalent (CO2e). No carbon offsets are used.

References:

CVI data on file, 2023-2025 CVI data on file, 2024. CVI data on file, 2025. International Sustainability & Carbon Certification, 2025, https://iscc-system.org/about/who-we-are.] CVI data on file, 2023. CVI data on file, 2021-2025. CVI data on file, 2024-2025. CVI data on file as of 03/2026. Plastic Bank, CVI data on file, 2025 SA17810/APP163993

About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world's leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric, and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life's beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision
[email protected] or +1.585.434.2148

SOURCE CooperVision, Inc.

Investors interested in Medical - Dental Supplies stocks are likely familiar with The Cooper Companies (COO) and Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?

Shahar Tamari, Chief Operating Officer (COO) of Global-E Online (GLBE 0.81%), reported the sale of 25,949 shares of Common Stock for approximately $903,000, according to an SEC Form 4 filing.

Transaction summaryMetricValueShares sold (direct)25,949Transaction value$902,766Post-transaction shares (direct)3,790,225Post-transaction value (direct ownership)$128.53 millionTransaction value based on SEC Form 4 reported price ($34.79); post-transaction value based on April 17, 2026, market close ($33.91).

Key questionsHow does this sale compare to Shahar's historical trading activity?
This was the largest single-day sale by Shahar in the past five transactions, with the previous maximum at 16,666 shares, indicating a step-up in dollar volume but still representing less than 1% of direct holdings.What is the current scale of Shahar's ownership relative to the company's equity?
After the transaction, Tamari directly holds 3,790,225 shares, equating to approximately 2.24% of the company's outstanding shares as of the latest available data.Were any derivative securities or indirect holdings involved in this transaction?
The transaction involved only directly held Common Stock, with no sales from indirect accounts or derivative exercises.Does the sale reflect a change in trading cadence or capacity?
The transaction size increased versus prior sales, but this is explained by capacity: Tamari's aggregate holdings remain largely intact, and the percentage sold is consistent with recent activity, suggesting routine portfolio management rather than a strategic shift.Company overviewMetricValueRevenue (TTM)$962.20 millionNet income (TTM)$68.27 millionEmployees1,2191-year price change5.51*1-year price change calculated as of April 20, 2026.

Company snapshotProvides a technology platform enabling direct-to-consumer cross-border e-commerce, facilitating online transactions for international shoppers and merchants.Targets online retailers and brands seeking to expand internationally, with a focus on merchants in Israel, the United Kingdom, the United States, and other global markets.Global-E Online Ltd. operates at scale as a cross-border e-commerce enabler, supporting over 1,000 employees and driving nearly $1 billion in annual revenue. The company’s strategy centers on providing seamless international shopping experiences for both merchants and consumers, leveraging proprietary technology and a global network.

What this transaction means for investorsGlobal E-Online has performed well, rising 5.51% over the past year (as of April 20). So why did its COO, Shahar Tamari, sell part of his stock holdings? In this case, it appears to be a minor transaction unrelated to stock performance or future outlook, as it represented approximately 1% of his total holdings.

Based in Israel, the company has been making steady progress as a leading cross-border e-commerce platform. This is an industry that has seen recent volatility due to geopolitical issues such as tariffs.

Its main attraction is its software program aimed at simplifying international commerce between merchants and consumers, and it has recently partnered with major consumer and luxury brands such as Victoria’s Secret (VSCO +6.12%) and Harrods. In general, growth appears strong as more consumers embrace global trade, and analysts expect earnings to trend upward.

Pamela Kock has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Global-E Online and Victoria's Secret & Co. The Motley Fool has a disclosure policy.

May 04, 2026 16:15 ET  | Source: CooperCompanies

SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board.

“We are delighted to welcome Paul to our Board as a new Director,” said Colleen Jay, Chair of the Board of CooperCompanies. “His experience as a CEO in the medical device sector, along with a successful track record of leading complex global operations, will be a significant asset as Cooper continues to execute its strategy and create long-term value for patients, customers, and shareholders.”

Mr. Keel has served as President and Chief Executive Officer of Envista Holdings Corporation (NYSE: NVST), a global specialty medical technology company, since 2024. Prior to joining Envista, Mr. Keel served as CEO of Smiths Group plc (LON: SMIN), a diversified global industrial technology company and FTSE constituent, from 2021 to 2024. Earlier, he spent 16 years at 3M, serving in various leadership roles, including Group President of 3M Consumer Business, President of 3M Medical, President of 3M Unitek, SVP of Manufacturing & Supply Chain, and SVP of Marketing, Sales & Business Development. Mr. Keel’s career also includes roles at General Mills, General Electric, Norwest Equity Partners, and McKinsey & Company. He holds an MBA from Harvard Business School and a BA in Economics from Carleton College.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Forward-Looking Statements

This press release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to the Company’s efforts to enhance long-term shareholder value, plans, strategies, future actions, and other statements of which are other than statements of historical fact, are forward-looking. Forward-looking statements necessarily depend on assumptions, data, or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Statements regarding future events and performance and contain words such as “expects” and similar words or phrases. A wide range of factors could materially affect future developments, including, but not limited to, uncertainties related to market conditions and other factors set forth in our other filings with the United States Securities and Exchange Commission, including our most recent Annual Report on Form 10-K. These risks and uncertainties may cause actual future results or actions to be materially different than those expressed in such forward-looking statements. We do not intend, or undertake any duty, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Contact:

Kim Duncan

Vice President, Investor Relations and Risk Management

925-460-3663

[email protected]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: The Cooper Companies (COO - Free Report) The Cooper Companies is a global medical device company operating through two main segments: CooperVision (CVI) and CooperSurgical (CSI). CVI focuses on contact lenses, with a strong presence in daily silicone hydrogel lenses, torics, multifocals, and myopia management. Its flagship MyDay franchise, including MyDay Energys and toric/multifocal expansions, continues to capture premium share, while MiSight addresses the growing myopia epidemic. CSI provides products and services in fertility and women’s health, offering in-vitro fertilization (IVF) solutions, contraceptives such as Paragard, and office/surgical devices.

COO is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.

It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 13.2; value investors should take notice.

One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $4.62 per share. COO boasts an average earnings surprise of +4.1%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, COO should be on investors' short list.

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min

SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026.

Second quarter 2026 revenue of $1.082 billion, up 8%, or up 5% organically, from last year's second quarter.Second quarter 2026 GAAP diluted earnings per share (EPS) of $(0.40), down $0.84 from last year's second quarter driven by a litigation-related charge to resolve outstanding claims associated with a December 2023 voluntary product recall at CooperSurgical.Second quarter 2026 Non-GAAP diluted EPS of $1.21, up $0.25 or 26% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below.
"We delivered a strong second quarter, achieving record revenue and non-GAAP earnings per share while marking our tenth consecutive quarter of exceeding consensus earnings expectations," said Al White, CooperCompanies' President and CEO. "Our performance reflects solid execution across our businesses, supported by new product launches, favorable demand drivers, and ongoing focus on operational discipline. In addition, we have reached agreements to resolve substantially all of the claims related to CooperSurgical's fertility media recall, representing an important step in addressing this issue and allowing us to move forward with our strategic review. Moving forward, we are focused on driving sustainable, profitable growth and strong cash flow, while maintaining discipline in a dynamic operating environment."

Second Quarter Operating Results

Revenue of $1.082 billion, up 8% from last year’s second quarter, up 5% in constant currency, up 5% organically.Gross margin of 68% similar to last year's second quarter. On a non-GAAP basis, gross margin was also similar to last year at 68%, with positive FX offsetting higher costs including tariffs.Operating margin of negative 3% compared with 18% in last year’s second quarter, primarily reflecting higher SG&A expenses, due to a $271.6 million litigation-related charge. On a non-GAAP basis, operating margin was up 260 basis points from last year to 27%, reflecting disciplined execution and meaningful synergies from last year's reorganization.Interest expense of $20.9 million compared with $24.2 million in last year's second quarter driven by lower interest rates and lower average debt. On a non-GAAP basis, interest expense was $20.9 million, down from $23.5 million.Cash provided by operations of $182.8 million, offset by capital expenditures of $86.4 million resulted in free cash flow of $96.4 million.
Second Quarter CooperVision (CVI) Revenue

Revenue of $723.5 million, up 8% from last year’s second quarter, up 4% in constant currency, up 4% organically.Revenue by category:     % change y/y  (In millions) Reported
 Currency Impact
 Constant Currency
 Acquisitions and Divestitures
 Organic
  2Q26      Toric and multifocal$364.9 11% (4)% 7% —% 7% Sphere, other 358.6 5% (4)% 1% —% 1% Total$723.5 8% (4)% 4% —% 4%                    Revenue by geography:
    % change y/y  (In millions) Reported
 Currency Impact
 Constant Currency
 Acquisitions and Divestitures
 Organic
  2Q26      Americas$303.2 7% —% 7% —% 7% EMEA 289.7 17% (11)% 6% —% 6% Asia Pacific 130.6 (6)% —% (6)% —% (6)% Total$723.5 8% (4)% 4% —% 4%                    Second Quarter CooperSurgical (CSI) Revenue

Revenue of $358.0 million, up 8% from last year's second quarter, up 6% in constant currency, up 6% organically.
Revenue by category:
    % change y/y  (In millions) Reported
 Currency Impact
 Constant Currency
 Acquisitions and Divestitures
 Organic
  2Q26      Office and surgical$214.2 4% —% 4% —% 4% Fertility 143.8 13% (3)% 10% —% 10% Total$358.0 8% (2)% 6% —% 6%                    Other

During the second quarter, the Company repurchased $13.1 million of common stock, approximately 174 thousand shares, at an average share price of $75.84. The program has $860.8 million of remaining availability.Recorded a $271.6 million net pre-tax charge within SG&A related to certain product-related litigation matters associated with a December 2023 voluntary recall of embryo culture media at CooperSurgical, consisting of $324.1 million of accrued litigation liabilities, partially offset by $52.5 million of expected insurance recoveries. Fiscal Year 2026 Financial Guidance

The Company updated its fiscal year 2026 financial guidance. Details are summarized as follows:

Fiscal 2026 total revenue of $4.285 - $4.321 billion (organic growth of 3.5% to 4.5%) CVI revenue of $2.883 - $2.908 billion (organic growth of 3.5% to 4.5%)CSI revenue of $1.402 - $1.414 billion (organic growth of 4% to 5%) Fiscal 2026 non-GAAP diluted EPS of $4.58 - $4.66Reaffirm previously communicated long-term free cash flow objective exceeding $2.2 billion for fiscal years 2026 through 2028
Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and certain income or gains and charges or expenses including acquisition and integration costs which we may incur as part of our continuing operations.

With respect to the Company’s guidance expectations, the Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses, which are reconciling items between the non-GAAP and GAAP measures. Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, the Company is not able to provide such guidance.

Reconciliation of Selected GAAP Results to Non-GAAP Results

To supplement our financial results and guidance presented on a GAAP basis, we provide non-GAAP measures such as non-GAAP gross margin, non-GAAP operating margin, non-GAAP diluted earnings per share, as well as constant currency and organic revenue growth because we believe they are helpful for the investors to understand our consolidated operating results. Management uses supplemental non-GAAP financial measures internally to understand, manage and evaluate our business, to make operating decisions, and to plan and forecast for future periods. The non-GAAP measures exclude costs which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. We provide further details of the non-GAAP adjustments made to arrive at our non-GAAP measures in the GAAP to non-GAAP reconciliations below. Our non-GAAP financial results and guidance are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

To present constant currency revenue growth, current period revenue for entities reporting in currencies other than the United States dollar are converted into United States dollars at the average foreign exchange rates for the corresponding period in the prior year. To present organic revenue growth, we excluded the effect of foreign currency fluctuations and the impact of any acquisitions, divestitures and discontinuations that occurred in the comparable period.

We define the non-GAAP measure of free cash flow as cash provided by operating activities less capital expenditures. We believe free cash flow is useful for investors as an additional measure of liquidity because it represents cash that is available to grow the business, make strategic acquisitions, repay debt, or buyback common stock. Management uses free cash flow internally to understand, manage, make operating decisions and evaluate our business. In addition, we use free cash flow to help plan and forecast future periods.

Investors should consider non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP.

THE COOPER COMPANIES, INC. AND SUBSIDIARIES GAAP to Non-GAAP Reconciliation
Gross Margin, Operating Margin, and EPS  Three Months Ended April 30,Six Months Ended April 30,(In millions) 2026Margin % 2025Margin % 2026Margin % 2025Margin %GAAP Gross Profit$735.468%$679.168%$1,430.668%$1,339.368%Acquisition and integration-related charges(1) ——% 2.2—% ——% 3.8—%Exit of business(2) ——% ——% 1.8—% ——%Medical device regulations(3) 0.7—% 0.7—% 1.4—% 1.3—%Total 0.7—% 2.9—% 3.2—% 5.1—%Non-GAAP Gross Profit$736.168%$682.068%$1,433.868%$1,344.468%  Three Months Ended April 30,Six Months Ended April 30,(In millions) 2026 Margin % 2025Margin % 2026Margin % 2025Margin %GAAP Operating Income (Loss)$(31.0)(3)%$184.818%$181.89%$366.819%Amortization of acquired intangibles 47.7 4% 49.85% 95.65% 99.45%Acquisition and integration-related charges(1) — —% 9.61% ——% 13.91%Exit of business(2) — —% ——% 1.8—% ——%Medical device regulations(3) 2.6 —% 5.31% 6.9—% 10.7—%Business optimization charges(4) 1.1 —% ——% 3.0—% ——%Other(5) 276.8 26% ——% 283.513% 0.6—%Total 328.2 30% 64.77% 390.818% 124.66%Non-GAAP Operating Income$297.2 27%$249.525%$572.627%$491.425%  Three Months Ended April 30,Six Months Ended April 30,(In millions, except per share amounts) 2026 EPS 2025 EPS 2026 EPS 2025 EPSGAAP Net Income (Loss)$(77.9)$(0.40)$87.7 $0.44 $52.9 $0.27 $192.0 $0.96 Amortization of acquired intangibles 47.7  0.24  49.8  0.24  95.6  0.48  99.4  0.49 Acquisition and integration-related charges(1) —  —  9.6  0.05  —  —  13.9  0.07 Exit of business(2) —  —  —  —  1.8  0.01  —  — Medical device regulations(3) 2.6  0.01  5.3  0.02  6.9  0.03  10.7  0.05 Business optimization charges(4) 1.1  0.01  —  —  3.0  0.02  —  — Other(5) 277.6  1.42  17.4  0.09  285.2  1.46  19.9  0.10 Tax effects related to the above items (55.4) (0.28) (11.1) (0.06) (70.6) (0.36) (25.8) (0.13)Intra-entity asset transfers(6) 41.7  0.21  34.8  0.18  79.6  0.40  67.8  0.34 Total 315.3  1.61  105.8  0.52  401.5  2.04  185.9  0.92 Non-GAAP Net Income$237.4 $1.21 $193.5 $0.96 $454.4 $2.31 $377.9 $1.88 Weighted average diluted shares used 195.6   200.7   196.1   200.9                    EPS, amounts and percentages may not sum or recalculate due to rounding.

(1) There were no acquisition and integration-related charges in the three and six months ended April 30, 2026.

The acquisition and integration-related charges in fiscal 2025 were primarily related to the obp Surgical and Cook Medical acquisition and integration expenses. Charges included $3.5 million and $4.8 million related to redundant personnel costs for transitional employees, $1.1 million and $2.4 million of professional services fees, $1.2 million and $2.1 million of inventory fair value step-up amortization, $1.1 million and $1.8 million of facility rationalization costs, and $0.3 million and $0.4 million of other acquisition and integration-related activities in the three and six months ended April 30, 2025. The three months ended April 30, 2025 also included $2.4 million of acquisition-related non-cash cumulative true-up adjustments reflecting changes in compensation.

Charges in this category may include the direct effects of acquisition accounting, such as amortization of inventory fair value step-up, professional services fees, regulatory fees, and items related to integrating acquired businesses, such as redundant personnel costs for transitional employees, acquisition-related non-cash cumulative true up adjustments reflecting changes in compensation, other acquisition-related costs, integration-related professional services, long-lived asset write-offs, manufacturing integration costs, legal entity and facility rationalization, and other integration-related activities.

(2) There were no charges related to the exit of business in the three months ended April 30, 2026. The six months ended April 30, 2026 included $1.7 million of specifically-identified long-lived asset write-offs and $0.1 million of other costs related to product line exits.

There were no exit of business charges in the three and six months ended April 30, 2025.

Charges in this category may include costs related to product line exits such as inventory write-offs, employee severance costs, and specifically-identified long-lived asset write-offs.

(3) Charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations and the E.U. in vitro diagnostic medical device regulation (collectively, the "Medical device regulations") for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be limited to a specific time period.

(4) Charges included $1.1 million and $2.3 million of redundant personnel costs for transitional employees in the three and six months ended April 30, 2026. The six months ended April 30, 2026 also included $0.4 million of employee severance costs and $0.3 million of other business optimization charges.

There were no business optimization charges in the three and six months ended April 30, 2025.

Charges in this category represent costs associated with initiatives to increase efficiency and optimize the cost structure, and may include, among other items, changes to our IT infrastructure and operations, employee severance costs, redundant personnel costs for transitional employees, legal entity and other business reorganizations, and inventories associated with the business optimization activities.

(5) Charges included $4.5 million and $11.2 million related to legal matters and $0.9 million and $1.8 million of gains and losses on minority interest investments in the three and six months ended April 30, 2026. The three months ended April 30, 2026 also included $272.2 million related to litigation expense and associated legal costs.

Charges in the three months ended April 30, 2025 included $16.7 million of gains and losses on minority interest investments, of which $15.7 million was related to loss on disposal of a minority interest investment, and $0.7 million of accretion of interest attributable to acquisition installment payables. Charges in the six months ended April 30, 2025 included $17.9 million of gains and losses on a minority interest investment, $1.4 million of accretion of interest attributable to acquisition installment payables, and $0.6 million legal fees.

Charges in this category may include legal matters, litigation expense, and other items that are not part of ordinary operations. The adjustments to arrive at non-GAAP net income also include gains and losses on minority interest investments and accretion of interest attributable to acquisition installment payables.

(6) In fiscal 2021, the Company transferred its CooperVision intellectual property and goodwill to its UK subsidiary. As a result, we recorded a deferred tax asset equal to approximately $2.0 billion as a one-time tax benefit in accordance with U.S. GAAP in fiscal 2021 as subsequently adjusted for changes in UK tax law. The non-GAAP adjustments reflect the ongoing net deferred tax benefit from tax amortization each period under UK tax law.

Audio Webcast and Conference Call

The Company will host an audio webcast today for the public, investors, analysts and news media to discuss its second quarter results and current corporate developments. The audio webcast will be broadcast live on CooperCompanies' website, www.investor.coopercos.com, at approximately 5:00 PM ET. It will also be available for replay on CooperCompanies' website, www.investor.coopercos.com. Alternatively, you can dial in to the conference call at 800-715-9871; conference ID 6529381.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life's beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women's healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Forward-Looking Statements

This earnings release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements of which are other than statements of historical fact, including our fiscal year 2026 financial guidance, are forward looking. In addition, all statements regarding anticipated growth in our revenues, expected savings from reorganization activities, anticipated effects of any product recalls, anticipated market conditions, planned product launches, restructuring or business transition expectations, regulatory plans, and expected results of operations and integration of any acquisition are forward-looking. To identify these statements look for words like "believes," "outlook," "probable," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates" or "anticipates" and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties.

Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: adverse changes in the global or regional general business, political and economic conditions including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items; the impact of international conflicts, including the ongoing conflict in the Middle East, and the global response to international conflicts on the global and local economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, or around, affected countries; our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of legal, compliance and regulatory requirements; the actual imposition or threats of tariffs, customs duties and fees by the U.S. government and other nations in response and other retaliatory actions, such as trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers, as well as the impact of the Company’s efforts to mitigate the effects of such tariffs or similar measures; foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings; our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds; changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income; acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms); compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information such as the Health Insurance Portability and Accountability Act of 1996 and the California Consumer Privacy Act in the U.S. and the General Data Protection Regulation requirements in Europe, including but not limited to those resulting from data security breaches; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to challenges associated with integration of acquisitions, man-made or natural disasters, pandemic conditions, cybersecurity incidents or other causes; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to the failure to perform by third-party vendors, including cloud computing providers or other technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades; a successful cybersecurity attack which could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data; market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers; disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR) and the EU In Vitro Diagnostic Medical Devices Regulation; legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement, contractual disputes, or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors' expansion through acquisitions; reduced sales, loss of customers, reputational harm and costs and expenses, including from claims and litigation related to product recalls and warning letters; failure to receive, or delays in receiving, regulatory approvals or certifications for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payers for our products and services; the requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment; the success of our research and development activities and other start-up projects; dilution to earnings per share from acquisitions or issuing stock; impact and costs incurred from changes in accounting standards and policies; risks related to environmental laws and requirements applicable to our facilities, products or manufacturing processes, including evolving regulations regarding the use of hazardous substances or chemicals in our products; risks related to environmental, social and corporate governance issues, including those related to regulatory and disclosure requirements, climate change and sustainability; and other events described in our United States Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, as such Risk Factors may be updated in annual and quarterly filings.

We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any obligation to update or revise them except as required by law.

Contact:

Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]

THE COOPER COMPANIES, INC. AND SUBSIDIARIESConsolidated Condensed Balance Sheets
(In millions)
(Unaudited)     April 30, 2026 October 31, 2025ASSETSCurrent assets:   Cash and cash equivalents$138.8 $110.6Trade receivables, net 809.2  829.0Inventories 896.4  846.0Prepaid expense and other current assets 455.4  320.8Total current assets 2,299.8  2,106.4Property, plant and equipment, net 2,132.2  2,082.0Goodwill 3,888.5  3,853.4Other intangibles, net 1,494.3  1,586.3Deferred tax assets 1,994.7  2,077.5Other assets 672.8  689.2Total assets$12,482.3 $12,394.8    LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities:   Short-term debt$598.9 $47.8Accounts Payable 233.3  300.4Employee compensation and benefits 165.9  210.6Deferred revenue 127.9  127.9Accrued litigation liability 324.8  0.7Other current liabilities 353.9  425.4Total current liabilities 1,804.7  1,112.8Long-term debt 1,861.3  2,457.5Deferred tax liabilities 96.4  93.3Long-term tax payable 5.6  7.5Deferred revenue 208.8  201.8Other liabilities 266.4  282.8Total liabilities 4,243.2  4,155.7Stockholders’ equity 8,239.1  8,239.1Total liabilities and stockholders' equity$12,482.3 $12,394.8 THE COOPER COMPANIES, INC. AND SUBSIDIARIESConsolidated Condensed Statements of Income (Loss)
(In millions, except per share amounts)
(Unaudited)     Three Months Ended April 30, Six Months Ended April 30,  2026  2025
  2026  2025
Net sales$1,081.5  $1,002.3 $2,105.6  $1,967.0Cost of sales 346.1   323.2  675.0   627.7Gross profit 735.4   679.1  1,430.6   1,339.3Selling, general and administrative expense 676.2   399.0  1,066.4   786.9Research and development expense 42.5   45.5  86.8   86.2Amortization of intangibles 47.7   49.8  95.6   99.4Operating income (loss) (31.0)  184.8  181.8   366.8Interest expense 20.9   24.2  43.3   50.2Other (income) expense, net (3.5)  16.1  (5.3)  18.8Income (loss) before income taxes (48.4)  144.5  143.8   297.8Provision for income taxes 29.5   56.8  90.9   105.8Net income (loss)$(77.9) $87.7 $52.9  $192.0        Earnings (loss) per share - diluted$(0.40) $0.44 $0.27  $0.96        Number of shares used to compute diluted earnings (loss) per share 195.0   200.7  196.1   200.9               EPS, amounts and percentages may not sum or recalculate due to rounding.

THE COOPER COMPANIES, INC. AND SUBSIDIARIESGAAP to Non-GAAP Reconciliation
Constant Currency Revenue Growth and Organic Revenue Growth   Net Sales    % change y/y  (In millions) Reported
 Currency Impact
 Constant Currency
 Acquisitions and Divestitures
 Organic
 2Q26     CooperVision$723.5 8% (4)% 4% —% 4%CooperSurgical 358.0 8% (2)% 6% —% 6%Total$1,081.5 8% (3)% 5% —% 5%

Have you evaluated the performance of The Cooper Companies' (COO - Free Report) international operations for the quarter ending April 2026? Given the extensive global presence of this surgical and contact lens products maker, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.

The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become essential for investors to comprehend how much a company relies on these foreign markets, as this understanding reveals the firm's potential for consistent earnings, its capacity to harness different economic cycles, and its overall growth prospects.

Being present in foreign markets serves as protection against local economic declines and helps benefit from more rapidly expanding economies. Yet, such expansion also introduces challenges related to currency fluctuations, geopolitical uncertainties and varied market behaviors.

While analyzing COO's performance for the last quarter, we found some intriguing trends in revenues from its overseas segments that Wall Street analysts commonly model and monitor.

The company's total revenue for the quarter stood at $1.08 billion, increasing 7.9% year over year. Now, let's delve into COO's international revenue breakdown to gain insights into the significance of its operations beyond home turf.

A Look into COO's International Revenue StreamsOf the total revenue, $289.7 million came from EMEA during the last fiscal quarter, accounting for 26.8%. This represented a surprise of +5.18% as analysts had expected the region to contribute $275.45 million to the total revenue. In comparison, the region contributed $282.3 million, or 27.6%, and $248.6 million, or 24.8%, to total revenue in the previous and year-ago quarters, respectively.

Asia Pacific generated $130.6 million in revenues for the company in the last quarter, constituting 12.1% of the total. This represented a surprise of -0.17% compared to the $130.83 million projected by Wall Street analysts. Comparatively, in the previous quarter, Asia Pacific accounted for $123.8 million (12.1%), and in the year-ago quarter, it contributed $138.6 million (13.8%) to the total revenue.

International Revenue PredictionsThe current fiscal quarter's total revenue for The Cooper Companies, as projected by Wall Street analysts, is expected to reach $1.12 billion, reflecting an increase of 5.6% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: EMEA is anticipated to contribute 27.3% or $305.46 million, and Asia Pacific 12.8% or $143.73 million.

For the entire year, the company's total revenue is forecasted to be $4.31 billion, which is an improvement of 5.4% from the previous year. The revenue contributions from different regions are expected as follows: EMEA will contribute 26.6% ($1.15 billion), and Asia Pacific 12.8% ($552.45 million) to the total revenue.

Key TakeawaysThe dependency of The Cooper Companies on global markets for its revenues presents a mix of potential gains and hazards. Thus, monitoring the trends in its overseas revenues can be a key indicator for predicting the firm's future performance.

In a world where international interdependencies and geopolitical conflicts are ever-increasing, Wall Street analysts closely monitor these trends for companies having international presence to adjust their earnings forecasts. Of course, there are several other factors, including a company's standing within its home borders, that influence analysts' earnings forecasts.

We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.

The Zacks Rank, our proprietary stock rating mechanism, demonstrates a notable performance history confirmed through external audits. It effectively utilizes the power of earnings estimate revisions to act as a predictor of a stock's price performance in the near term.

The Cooper Companies, bearing a Zacks Rank #3 (Hold), is expected to mirror the broader market's movements in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Assessing The Cooper Companies' Stock Price Movement in Recent TimesOver the preceding four weeks, the stock's value has appreciated by 12.2%, against an upturn of 1.9% in the Zacks S&P 500 composite. In parallel, the Zacks Medical sector, which counts The Cooper Companies among its entities, has appreciated by 3.1%. Over the past three months, the company's shares have seen a decline of 3.7% versus the S&P 500's 8.5% increase. The sector overall has witnessed a decline of 3.3% over the same period.